1
|
Pan HD, Zhang Y, Tang H, Yang JLX, Feng WW, Mu LJ, Yan DM, Shao J, Wang H, Gao XT, Zhu RK, Huang GW, Zhao DM, Luo Y, Lyu LQ, Sun J, Yang J, Yan SQ, Wang NR, Wang H. [Studies of the norm of Karitane Parenting Confidence Scale(KPCS)among parents of infants in urban areas of China]. Zhonghua Yu Fang Yi Xue Za Zhi 2021; 55:1209-1213. [PMID: 34706506 DOI: 10.3760/cma.j.cn112150-20210224-00180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To establish the norm of the Chinese version of Karitane Parenting Confidence Scale (KPCS) in urban areas of China. Methods: From August to December 2017, the parents of 2 216 children (<36 months old) were selected from 15 cities (Beijing, Lianyungang, Hangzhou, Chengdu, Xi'an, Guangzhou, Changsha, Jinan, Guiyang, Ningbo, Dalian, Qinhuangdao, Maanshan, Chongqing and Wuhan) in 14 provinces by stratified random sampling. The general demographic characteristics and parents' parenting confidence were collected by a self-made questionnaire and KPCS Chinese version. The percentile norm was established. P3, P10 and P25 were used as the criteria to define the degree of lack of parenting confidence. Results: The age of mothers was (30.67±4.29). The age of the father was (32.50±4.99) years old. There were 726 (32.76%), 759 (34.25%) and 731 (32.99%) infants in 6-12, 12-23 and 24-35 months old groups. The total scores of P50, P25, P10 and P3 of KPCS (Chinese version) of infant parents in urban areas in China were 41, 38, 33, and 29 respectively. When the scores of parents were 34-37, 30-33, and ≤ 29, they were judged as mild, moderate, and severe lack of parenting confidence. There was no significant difference in the Chinese version of KPCS between parents of different age groups and parents of different gender (χ²=3.53, P=0.171; χ²=1.41, P=0.236). Each factor score≤P3 is defined as the boundary score, and the corresponding boundary scores of "parenting" "support" and "competence" were 13, 9, and 5 respectively. Conclusion: The Chinese version of KPCS can be used to assess the parenting confidence of infants in urban areas of China. It can used as one of the bases for scientific and objective evaluation of the parenting status of families.
Collapse
Affiliation(s)
- H D Pan
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - Y Zhang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - H Tang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - J L X Yang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - W W Feng
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - L J Mu
- Early Childhood Integrated Development Service Center,Fangshan District Maternal and Child Health Hospital, Beijing 102488, China
| | - D M Yan
- Child Growth & Development,Lianyungang Maternal and Child Health Hospital, Lianyungang 222000, China
| | - J Shao
- Children's Health Care Department, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
| | - H Wang
- Children's Health Care Department, Sichuan Province Maternal and Child Health Hospital, Chengdu 610031, China
| | - X T Gao
- Children's Health Care Department, Northwest Women and Children's Hospital, Xi'an 710061, China
| | - R K Zhu
- Children's Health Care Department, Guangdong Province Maternal and Child Health Hospital, Guangzhou 510010, China
| | - G W Huang
- Children's Health Care Department, Hunan Province Maternal and Child Health Hospital, Changsha 410008, China
| | - D M Zhao
- Children's Health Care Department, Qilu Children's Hospital of Shandong University, Jinan 250022, China
| | - Y Luo
- Children's Health Care Department, Guiyang Maternal and Child Health Hospital, Guiyang 550003, China
| | - L Q Lyu
- Children's Health Care Department, Ningbo Women and Children's Hospital, Ningbo 315000, China
| | - J Sun
- Children's Health Care Department, Dalian Maternal and Child Health Hospital, Dalian 116033, China
| | - J Yang
- Children's Health Care Department, Qinhuangdao Maternal and Child Health Hospital, Qinhuangdao 066001, China
| | - S Q Yan
- Children's Health Care Department, Maanshan Maternal and Child Health Hospital, Maanshan 243011, China
| | - N R Wang
- Children's Health Care Department, Chongqing Maternal and Child Health Hospital, Chongqing 400013, China
| | - H Wang
- Children's Health Care Department, Hubei Province Maternal and Child Health Hospital, Wuhan 430070, China
| |
Collapse
|
2
|
Yang JLX, Zhang Y, Feng WW, Tang H, Shao J, Wang NR, Wang H, Sun J, Luo Y, Lyu LQ, Yan SQ, Zhao DM, Mu LJ, Yan DM, Wang H, Gao XT, He MF, Yang J, Fu M, Sanders M, Haslam D. [Practice of parenting and related factors on children aged 0-5 in the urban areas of China]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40:422-426. [PMID: 31006202 DOI: 10.3760/cma.j.issn.0254-6450.2019.04.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Objective: To characterize the relations between the practice of parenting and associated factors on children (0-5 years old) in urban areas of China, in order to provide evidence for promoting the early development of children and to provide positive guidance and service programs on parenting. Methods: A total of 4 515 parents from 15 cities (14 provinces) were surveyed with a self-administered questionnaire. Parenting and Family Adjustment Scales (PAFAS) was used, including parameters as: consistency and coercive parenting, positive encouragement, parent-child relationship and parental emotion adjustment, family relationship and parental teamwork aspects, etc. Both single factor analysis and multiple linear regression were used to examine the associations between parenting practice, individual, parental and family factors. Results: The mean score of PAFAS was 21.00 (15.00-28.00), associated with factors as children's age, only-child family, premature delivery, father's education level, confidence on parenting, problems regarding the parental mood, annual family income, family structure and behavior on seeking professional help, etc. Results showed that there were big differences on the practice of parenting in China and influenced by variety of factors. Conclusions: The general situation of parenting was well, in the urban areas of China. The practice of parenting was associated with a series of individual, parental and family factors. Programs on improving the parenting skills and promoting the early development of children, should be highlighted.
Collapse
Affiliation(s)
- J L X Yang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - Y Zhang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - W W Feng
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - H Tang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - J Shao
- Zhejiang University School of Medicine Affiliated Children's Hospital, Hangzhou 310003, China
| | - N R Wang
- Chongqing Maternal and Child Health Hospital, Chongqing 400013, China
| | - H Wang
- Maternal and Child Health Hospital of Sichuan Province, Chengdu 610031, China
| | - J Sun
- Dalian Maternal and Child Health Hospital of Liaoning Province, Dalian 116033, China
| | - Y Luo
- Guiyang Maternal and Child Health Hospital, Guiyang 550003, China
| | - L Q Lyu
- Ningbo Women and Children's Hospital of Zhejiang Province, Ningbo 315000, China
| | - S Q Yan
- Ma'anshan Maternal and Child Health Hospital of Anhui Province, Ma'anshan 243011, China
| | - D M Zhao
- Qilu Children's Hospital of Shandong University, Jinan 250022, China
| | - L J Mu
- Fangshan District Maternal and Child Health Hospital of Beijing, Beijing 102488, China
| | - D M Yan
- Lianyungang Maternal and Child Health Hospital of Jiangsu Province, Lianyungang 222000, China
| | - H Wang
- Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, China
| | - X T Gao
- Northwest Women and Children's Hospital, Xi'an710061, China
| | - M F He
- Maternal and Child Health Hospital Hunan Province, Changsha 410008, China
| | - J Yang
- Qinhuangdao Maternal and Child Health Hospital of Hebei Province, Qinhuangdao 066001, China
| | - M Fu
- Maternal and Child Health Hospital of Guangdong Province, Guangzhou 510010, China
| | - M Sanders
- The University of Queensland, Australia, Queensland 4072, Australia
| | - D Haslam
- The University of Queensland, Australia, Queensland 4072, Australia
| |
Collapse
|
3
|
Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G. Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer 2005; 93:749-56. [PMID: 16136047 PMCID: PMC2361645 DOI: 10.1038/sj.bjc.6602761] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Here, we present results from a clinical trial employing a new vaccination method using dendritic cells (DCs) transfected with mRNA from allogeneic prostate cancer cell lines (DU145, LNCaP and PC-3). In all, 20 patients were enrolled and 19 have completed vaccination. Each patient received at least four weekly injections with 2 × 107 transfected DCs either intranodally or intradermally. Safety and feasibility of vaccination were determined. Immune responses were measured as delayed-type hypersensitivity and by in vitro immunoassays including ELISPOT and T-cell proliferation in pre- and postvaccination peripheral blood samples. Serum prostate-specific antigen (PSA) levels and bone scans were monitored. No toxicity or serious adverse events related to vaccinations were observed. A total of 12 patients developed a specific immune response to tumour mRNA-transfected DCs. In total, 13 patients showed a decrease in log slope PSA. This effect was strengthened by booster vaccinations. Clinical outcome was significantly related to immune responses (n=19, P=0.002, r=0.68). Vaccination with mRNA-transfected DCs is safe and results in cellular immune responses specific for antigens encoded by mRNA derived from the prostate cancer cell lines. The observation that in some patients vaccination affected the PSA level suggests that this approach may become useful as a treatment modality for prostate cancer patients.
Collapse
Affiliation(s)
- L J Mu
- Section for Immunotherapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
- Laboratory of Cellular Therapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - J A Kyte
- Section for Immunotherapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - G Kvalheim
- Laboratory of Cellular Therapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - S Aamdal
- Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - S Dueland
- Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - M Hauser
- Department of Radiology, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - H Hammerstad
- Laboratory of Cellular Therapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - H Waehre
- Department of Surgery, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - N Raabe
- Department of Oncology, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
| | - G Gaudernack
- Section for Immunotherapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway
- Section for Immunotherapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo 0310, Norway. E-mail:
| |
Collapse
|
4
|
Mu LJ, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G. Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells. Int J Immunopathol Pharmacol 2005; 17:255-63. [PMID: 15461859 DOI: 10.1177/039463200401700305] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Enriched CD34(+) peripheral blood progenitor cells (PBPC) are frequently used as stem cell support in cancer patients following high dose therapy. Since precursor dendritic cells (DCs) originate from haematopoietic progenitor cells, purified CD34(+) cells might also serve as starting cells for ex- vivo production of DC. In the present study we developed a clinical grade procedure for ex- vivo production of DC derived from enriched CD34(+) cells. Different concentrations of CD34(+) cells were grown in gas-permeable Teflon bags with different serum-free and serum-containing media supplemented with GM-CSF, IL-4, TNF-alpha, SCF, Flt-3L and INF-alpha. Serum-free CellGroSCGM medium for 7 days followed by CellGroDC medium in 7 days gave the same results as serum-containing medium. After incubation the cultured cells containing immature DCs were concentrated and transfected with tumour mRNA from human prostate cancer cell lines employing a highly efficient electroporation procedure. Thawed transfected DCs were able to elicit primary T-cell responses in vitro against antigens encoded by the prostate cancer mRNA as shown by ELISPOT assay using mock-transfected DCs as control. Our results show that frozen enriched CD34(+) cells can be an alternative and efficient source for production of DCs for therapeutic purpose.
Collapse
Affiliation(s)
- L J Mu
- Laboratory for Cellular Therapy, Norwegian Radium Hospital, University of Oslo, Oslo, Norway
| | | | | | | | | |
Collapse
|
5
|
Mu LJ, Gaudernack G, Saebøe-Larssen S, Hammerstad H, Tierens A, Kvalheim G. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines. Scand J Immunol 2003; 58:578-86. [PMID: 14629630 DOI: 10.1046/j.1365-3083.2003.01333.x] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
With the aim of producing large quantities of mRNA-transfected monocyte-derived dendritic cells (DCs) to be used as cancer vaccines, a new clinical grade procedure has been developed. Peripheral blood mononuclear cells (PBMCs) obtained by leukapheresis were enriched for monocytes by immunomagnetic depletion of CD19+ B cells and CD2+ T cells employing the ISOLEX 300i device. After 5 days of culture of enriched monocytes in gas permeable Teflon bags, using serum-free medium supplemented with granulocyte/macrophage-colony stimulating factor and interleukin-4 (IL-4), immature DCs were generated. Following transfection with mRNA from three human prostate cancer cell lines (DU145, LNCaP and PC-3), employing a newly developed square wave electroporation procedure, the immature DCs were immediately transferred to Teflon bags and matured for 48 h, using serum-free medium supplemented with IL-1alpha, IL-6, tumour necrosis factor-alpha and PGE2. The electroporation procedure efficiently transferred mRNA into the DCs with minor effect on the viability of the cells. The generated matured transfected DCs show high expression of the antigens CD83, CD80, CD86 and human leucocyte antigen-DR. Freezing and thawing of the transfected matured DCs had minor effect on cell viability and the phenotype. From 4 x 109 PBMCs, about 1 x 108 transfected matured DCs are produced. The thawed transfected DCs were able to elicit primary T-cell responses in vitro against antigens encoded by the prostate cancer mRNA as shown by enzyme-linked immunospot assay using mock-transfected DCs as control. Based on these results, clinical trials in cancer patients have been initiated.
Collapse
Affiliation(s)
- L J Mu
- Laboratory for Cellular Therapy, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway
| | | | | | | | | | | |
Collapse
|